TABLE 4.
Secondary outcome measures at baseline and follow‐up.
| Outcome measure | Heel lift | Sham | Adjusted mean difference (95% CI) | p‐value | Cohen's d |
|---|---|---|---|---|---|
| Pain at its worst (NRS‐11) | |||||
| Baseline | 6.1 ± 1.3 | 6.8 ± 1.6 | |||
| 12 weeks | 2.9 ± 1.8 | 4.7 ± 2.0 | −1.5 (−3.0 to 0.1) | 0.06 | 0.94 |
| VISA‐A | |||||
| Baseline | 48.1 ± 14.9 | 34.6 ± 10.8 | |||
| 12 weeks | 73.3 ± 15.3 | 59.3 ± 16.8 | 5.5 (−7.5 to 18.6) | 0.39 | 0.87 |
| LEFS | |||||
| Baseline | 54.9 ± 7.2 | 47.5 ± 14.9 | |||
| 12 weeks | 69.1 ± 6.5 | 60.9 ± 13.0 | 4.6 (−3.0 to 12.1) | 0.22 | 0.79 |
| EQ‐5D‐5 L VAS | |||||
| Baseline | 71.8 ± 15.6 | 64.2 ± 16.9 | |||
| 12 weeks | 72.2 ± 16.1 | 61.9 ± 17.4 | 5.4 (−5.9 to 16.6) | 0.33 | 0.61 |
Note: *Statistically significant.
Abbreviations: EQ‐5D‐5 L VAS, EuroQol 5 Dimension 5 Level Visual Analogue Scale; LEFS, Lower Extremity Functional Scale; NRS, Numerical Rating Scale; VISA‐A, Victorian Institute of Sport Assessment—Achilles.